← Browse by Condition
Medical Condition

recurrent malignant solid neoplasm

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1
NCT04870944 Phase 1, Phase 2
Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Enrollment
63 pts
Location
United States, Austr...
Sponsor
Children's Oncology Group
View Trial →
NCT06295965
Recruiting

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Enrollment
2,000 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT04693468 Phase 1
Recruiting

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

Enrollment
111 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04119024 Phase 1
Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
View Trial →